Wird geladen...
Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial
BACKGROUND: Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3840690/ https://ncbi.nlm.nih.gov/pubmed/24165282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-13-175 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|